港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

抗疫概念

907.609

+11.0811.24%

涨家数：11

跌家数：7

平家数：- -

市盈率：- -

高：908.833

开：893.740

低：891.998

收：896.528

数据加载中...

总览新闻资讯

“太平洋医药”君实生物公司点评：拓益收入同比增长 46%，关注 DKK1 胃肠道肿瘤早期数据

复星医药子公司获美国FDA批准开展AGA治疗临床试验

山东新华制药股份(00719)收到依帕司他片《药品补充申请批准通知书》

复星医药(600196.SH)控股子公司获美国FDA药品临床试验批准

京东健康05月09日主力净流出825.6万元散户资金买入

中国中药05月09日获主力加仓60.1万元

国药控股05月09日获主力加仓257.3万元

复星医药05月09日遭主力抛售208.4万元

同源康医药-B05月09日获主力加仓917.9万元

比亚迪电子05月09日遭主力抛售367.2万元

中国生物制药05月09日主力净流入622.7万元散户资金抛售

我国首个国产罕见病特医食品上市阿里健康罕见病关爱平台首发

比亚迪“造人”加速：新能源巨头抢滩人形机器人新赛道

石药集团(01093)出现大手买入100万股，成交价$5.72，涉资572万

阿斯达克财经

第21个阿里日来临前：CEO吴泳铭呼吁“回归初心，重新创业”

阿里健康(00241)出现大手买入180万股，成交价$5.01，涉资901.8万

阿斯达克财经

歌礼制药-B：早盘涨 5.55% 肥胖症药物新进展

【银河医药程培】公司点评丨百济神州：海外放量超预期，创新管线迎来拐点

中国银河证券研究

歌礼制药-B早盘涨超5% 将公布肥胖症候选药物ASC47早期研究结果

京东健康盘中异动股价大跌3.02%报36.900港元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK1515/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"抗疫概念","latestPrice":907.6094,"timestamp":1747030572421,"preClose":896.528,"halted":0,"volume":365481655,"delay":0,"changeRate":0.01236,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":11.08136,"latestTime":"05-12 14:16:13","open":893.73975,"high":908.83264,"low":891.99774,"amount":2757084061,"amplitude":0.018778,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1747037400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1747013400000,1747022400000],[1747026000000,1747036800000]],"pbRate":1.585523,"peRate":21.198848,"turnoverRate":0.004966,"increases":11,"decrements":7,"flats":0,"marketCap":624743499648,"floatMarketCap":514704573568},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":908.83264,"amplitude":0.018778,"preClose":896.528,"low":891.99774,"pbRate":"1.585523","latestPrice":907.6094,"volume":365481655,"delay":0,"open":893.73975,"prevYearClose":787.97723,"prevWeekClose":896.528,"prevMonthClose":903.998,"prevQuarterClose":870.015,"fiveDayClose":921.416,"twentyDayClose":756.168,"sixtyDayClose":879.539,"secType":"PLATE","market":"HK","turnoverRate":0.004966,"peRate":21.198848,"marketCap":624743499648,"floatMarketCap":514704573568,"timestamp":1747030572421,"nameCN":"抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":11,"down":7,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2534991171","title":"“太平洋医药”君实生物公司点评：拓益收入同比增长 46%，关注 DKK1 胃肠道肿瘤早期数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2534991171","media":"新浪财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534991171?lang=zh_cn&edition=fundamental","pubTime":"2025-05-09 17:22","pubTimestamp":1746782527,"startTime":"0","endTime":"0","summary":"拓益销售收入保持高增速，公司运营效率显著提升，在手现金 30 亿元。2025 年第一季度公司实现收入 5 亿元， 其中，核心产品特瑞普利单抗于国内市场实现销售收入 4.47 亿元。研发费用 3.51 亿元，同比增加 26.89%；管理费用 0.97 亿元，同比减少 21.32%。拓益国内获批 12 项适应症，国际化布局进展顺利。截止目前，拓益已于国内获批 12 项适应症，10 项适应症纳入国家医保目录，其中 4 项为医保独家适应症。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050917245897544f69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050917245897544f69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09939","BK1583","01877","BK1515","BK1161"],"gpt_icon":0},{"id":"2534173533","title":"复星医药子公司获美国FDA批准开展AGA治疗临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2534173533","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534173533?lang=zh_cn&edition=fundamental","pubTime":"2025-05-09 16:37","pubTimestamp":1746779855,"startTime":"0","endTime":"0","summary":"5月9日，复星医药发布公告，控股子公司菌济健康获得美国FDA关于LBP-ShC4开展临床试验的批准。公告指出，目前全球尚无用于治疗雄激素脱发的活体生物治疗产品获批上市。尽管获得临床试验批准，但药品研发存在风险，后续的临床研究仍需获得美国药品审评部门的审批，且临床试验可能因安全性和有效性问题而终止。2025年一季度，复星医药实现收入94.20亿元，归母净利润7.65亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509164519a477e291&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509164519a477e291&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1576","BK1583","02196","BK1593","03347","BK1141","BK1515"],"gpt_icon":0},{"id":"2534917837","title":"山东新华制药股份(00719)收到依帕司他片《药品补充申请批准通知书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2534917837","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534917837?lang=zh_cn&edition=fundamental","pubTime":"2025-05-09 16:35","pubTimestamp":1746779710,"startTime":"0","endTime":"0","summary":"智通财经APP讯，山东新华制药股份(00719)发布公告，近日，该公司收到国家药品监督管理局核准签发的依帕司他片(以下简称“本品”)《药品补充申请批准通知书》，批准本品上市许可持有人转让补充申请。公告称，2025年5月，新华制药获得药品补充申请批准通知书，依帕司他片通过国家药品监督管理局审批，公司成为本品的上市许可持有人。该产品的上市，有利于丰富公司内分泌系统药物产品线，提升公司综合竞争优势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1291328.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1515","00719"],"gpt_icon":0},{"id":"2534120770","title":"复星医药(600196.SH)控股子公司获美国FDA药品临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2534120770","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534120770?lang=zh_cn&edition=fundamental","pubTime":"2025-05-09 16:29","pubTimestamp":1746779394,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复星医药(600196.SH)公告，公司控股子公司上海菌济健康科技有限公司(简称“菌济健康”)收到美国FDA(即美国食品药品监督管理局)关于同意LBP-ShC4开展临床试验的批准。菌济健康拟于条件具备后开展LBP-ShC4的I期临床试验。据悉，LBP-ShC4为集团(即公司及控股子公司/单位，下同)自主研发的活体生物治疗产品，拟用于治疗雄激素脱发(AGA)。截至本公告日期(2025年5月9日)，于全球范围内尚无用于治疗雄激素脱发(AGA)的活体生物治疗产品(包括单药或联合治疗方案)获批上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1291319.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0012","BK0196","BK1576","BK1593","BK1191","BK0060","BK0175","600196","BK1141","BK0096","BK1583","BK0188","BK1515","BK0028","BK0239","02196","BK0187","BK0183","03347"],"gpt_icon":0},{"id":"2534310654","title":"京东健康05月09日主力净流出825.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2534310654","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534310654?lang=zh_cn&edition=fundamental","pubTime":"2025-05-09 16:15","pubTimestamp":1746778550,"startTime":"0","endTime":"0","summary":"05月09日, 京东健康股价跌3.15%，报收36.85元，成交金额3.1亿元，换手率0.27%，振幅3.55%，量比1.08。京东健康今日主力资金净流出825.6万元，上一交易日主力净流入574.4万元。该股近5个交易日下跌1.62%，主力资金累计净流入6562.3万元；近20日主力资金累计净流入4.7亿元，其中净流入天数为16日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509180327a477fd7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509180327a477fd7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1571","BK1142","LU0051755006.USD","06618","86618","BK1589","LU0456827905.SGD","BK1247","BK1583","BK1515","BK1615","BK1591"],"gpt_icon":0},{"id":"2534170191","title":"中国中药05月09日获主力加仓60.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534170191","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534170191?lang=zh_cn&edition=fundamental","pubTime":"2025-05-09 16:15","pubTimestamp":1746778541,"startTime":"0","endTime":"0","summary":"05月09日，中国中药股价收平报2.08元，成交金额2548.3万元，换手率0.24%，振幅1.92%，量比0.61。中国中药今日主力资金净流入60.1万元，上一交易日主力净流入344.2万元。该股近5个交易日上涨2.48%，主力资金累计净流入2709.3万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入1.1亿元，其中净流入天数为17日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509175906a6d8eb18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509175906a6d8eb18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1606","BK1191","00570","BK1515"],"gpt_icon":0},{"id":"2534170479","title":"国药控股05月09日获主力加仓257.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534170479","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534170479?lang=zh_cn&edition=fundamental","pubTime":"2025-05-09 16:15","pubTimestamp":1746778538,"startTime":"0","endTime":"0","summary":"05月09日, 国药控股股价涨0.55%，报收18.40元，成交金额7251.9万元，换手率0.29%，振幅1.42%，量比0.54。国药控股今日主力资金净流入257.3万元，上一交易日主力净流入1491.3万元。该股近5个交易日上涨0.22%，主力资金累计净流入5375.7万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入2.0亿元，其中净流入天数为15日。该股主力净额占比0.01%，港股市场排名244/2645。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509175750a6d8ea8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509175750a6d8ea8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1500","BK1197","BK1515","LU0640798160.USD","LU1115378108.SGD","01099"],"gpt_icon":0},{"id":"2534102117","title":"复星医药05月09日遭主力抛售208.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534102117","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534102117?lang=zh_cn&edition=fundamental","pubTime":"2025-05-09 16:15","pubTimestamp":1746778532,"startTime":"0","endTime":"0","summary":"05月09日, 复星医药股价跌1.57%，报收13.78元，成交金额3165.9万元，换手率0.42%，振幅1.57%，量比0.48。复星医药今日主力资金净流出208.4万元，上一交易日主力净流出362.9万元。该股近5个交易日下跌1.43%，主力资金累计净流出404.6万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出351.4万元，其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509175423a6d8e98e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509175423a6d8e98e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","BK1593","02196"],"gpt_icon":0},{"id":"2534794101","title":"同源康医药-B05月09日获主力加仓917.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534794101","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534794101?lang=zh_cn&edition=fundamental","pubTime":"2025-05-09 16:15","pubTimestamp":1746778528,"startTime":"0","endTime":"0","summary":"05月09日, 同源康医药-B股价涨1.98%，报收30.95元，成交金额1.3亿元，换手率1.18%，振幅4.78%，量比1.26。同源康医药-B今日主力资金净流入917.9万元，上一交易日主力净流入1059.4万元。该股近5个交易日上涨7.09%，主力资金累计净流入2414.4万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入6401.6万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509175157a477f9b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509175157a477f9b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","09939","02410","BK1161","BK1574"],"gpt_icon":1},{"id":"2534381101","title":"比亚迪电子05月09日遭主力抛售367.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534381101","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534381101?lang=zh_cn&edition=fundamental","pubTime":"2025-05-09 16:15","pubTimestamp":1746778523,"startTime":"0","endTime":"0","summary":"05月09日, 比亚迪电子股价跌1.19%，报收33.35元，成交金额3.5亿元，换手率0.46%，振幅2.96%，量比0.66。比亚迪电子今日主力资金净流出367.2万元，连续3日净流出，上一交易日主力净流出1915.6万元。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为88.89%，平均跌幅为2.30%。该股近5个交易日上涨3.10%，主力资金累计净流入1555.6万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入1.3亿元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509174858a477f8cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509174858a477f8cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1580","LU0348767384.USD","BK1149","BK1540","BK1582","BK1589","LU0348766576.USD","00285","LU0274383008.USD","BK1504","BK1607","BK1515"],"gpt_icon":1},{"id":"2534117271","title":"中国生物制药05月09日主力净流入622.7万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2534117271","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534117271?lang=zh_cn&edition=fundamental","pubTime":"2025-05-09 16:15","pubTimestamp":1746778515,"startTime":"0","endTime":"0","summary":"05月09日, 中国生物制药股价涨0.77%，报收3.91元，成交金额2.5亿元，换手率0.35%，振幅2.58%，量比0.91。中国生物制药今日主力资金净流入622.7万元，上一交易日主力净流出1667.5万元。该股近5个交易日上涨0.26%，主力资金累计净流出500.1万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入9156.1万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509174632a477f7e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509174632a477f7e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1589","BK1521","01177","BK1191"],"gpt_icon":0},{"id":"2534762122","title":"我国首个国产罕见病特医食品上市阿里健康罕见病关爱平台首发","url":"https://stock-news.laohu8.com/highlight/detail?id=2534762122","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534762122?lang=zh_cn&edition=fundamental","pubTime":"2025-05-09 15:42","pubTimestamp":1746776520,"startTime":"0","endTime":"0","summary":"我国首个国产罕见病特医食品“特爱丙佳”在阿里健康平台首发，为甲基丙二酸血症和丙酸血症患者提供稳定便捷的特医食品供给，实现了国产罕见病特医食品零的突破。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050915592294f1845d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050915592294f1845d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1247","BK1502","BK1189","BK1617","BK1615","BK1589","BK1571","BK1501","BK1584","BK1610","00241","BK1142","BK1515","BK1591"],"gpt_icon":0},{"id":"2534412949","title":"比亚迪“造人”加速：新能源巨头抢滩人形机器人新赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2534412949","media":"新浪财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534412949?lang=zh_cn&edition=fundamental","pubTime":"2025-05-09 15:10","pubTimestamp":1746774658,"startTime":"0","endTime":"0","summary":"近期， 新能源 汽车领军企业 比亚迪 在人形 机器人 领域的动作频频，引发行业高度关注。这不仅是比亚迪本年度首笔重磅股权投资，更是其在 具身智能 领域迄今最大单笔投资，标志着新能源巨头正式加速布局 人形机器人 赛道。业内人士分析认为，比亚迪在新能源汽车智能化竞争中抢滩人形机器人赛道，不仅为汽车业务拓展了技术边界，更在智能制造、工业协作等领域开辟了全新增长曲线。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509151827a6d8b899&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509151827a6d8b899&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0509642566.USD","002594","LU0289961442.SGD","LU0054450605.USD","81211","LU2097828557.USD","SG9999015952.SGD","BK1515","LU0543330566.HKD","LU1794554557.SGD","LU2097828714.EUR","HYDD.SI","BYDDY","LU0307460666.USD","LU0516422952.EUR","SG9999015986.USD","LU0326950275.SGD","LU0979878070.USD","LU1719994722.HKD","LU0052750758.USD","BK1504","LU0175139822.USD","LU2097828631.EUR","BK1540","SG9999014674.SGD","LU1023057109.AUD","LU0650527681.SGD","01211","LU1251922891.USD","LU0572944931.SGD","BK1589","LU2399975544.HKD","LU0505663152.USD","BK1594","LU2097828805.USD","LU0274383008.USD","BK1580","LU0871576103.HKD","LU0320764599.SGD","LU0708995583.HKD","LU0634319403.HKD","LU0417516738.SGD","LU0588545730.USD","LU0084288322.USD","LU0516423174.USD","LU0823414478.USD","LU0348805143.USD","SG9999015945.SGD","LU2476274308.USD"],"gpt_icon":1},{"id":"2534254721","title":"石药集团(01093)出现大手买入100万股，成交价$5.72，涉资572万","url":"https://stock-news.laohu8.com/highlight/detail?id=2534254721","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534254721?lang=zh_cn&edition=fundamental","pubTime":"2025-05-09 14:43","pubTimestamp":1746772980,"startTime":"0","endTime":"0","summary":"[大手成交]石药集团(01093)在下午02:43出现大手买入，成交量为100万，成交价为港币$5.72，涉资572万。至目前为止，股价跌0.522%，今日最高价为$5.85，而最低价为$5.63，总成交量为7.025千万股，总成交金额港币$4.02亿。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126132515779_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126132515779_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2505096534/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU0072913022.USD","LU0326950275.SGD","LU1226287792.SGD","IE00B5MMRT66.SGD","BK1515","LU1226288253.USD","LU1226287529.USD","IE00BZ08YR35.GBP","SG9999004220.SGD","IE00B031HY20.USD","IE0008369823.USD","LU1152091168.USD","IE00B543WZ88.USD","LU0067412154.USD","LU1226287875.USD","IE00BZ08YT58.USD","LU1960683339.HKD","IE00BZ08YS42.EUR","LU1951186391.HKD","01093","BK1191","LU1152091754.HKD","LU1226288170.HKD","LU0140636845.USD","LU1993786604.SGD","LU0880133367.SGD","LU1807302812.USD","LU0501845795.SGD","IE0008368742.USD","LU1008478684.HKD","BK1521"],"gpt_icon":0},{"id":"2534314676","title":"第21个阿里日来临前：CEO吴泳铭呼吁“回归初心，重新创业”","url":"https://stock-news.laohu8.com/highlight/detail?id=2534314676","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534314676?lang=zh_cn&edition=fundamental","pubTime":"2025-05-09 12:43","pubTimestamp":1746765810,"startTime":"0","endTime":"0","summary":"5月9日，在第21个510阿里日来临前，阿里巴巴（09988）CEO吴泳铭通过内网发布题为《回归初心重新创业》的全员信，宣布集团将开启新一轮战略调整，强调以创业心态应对AI技术革命带来的机遇与挑战，并透露集团将聚焦“几大核心战役”，由多业务协同推进。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a6875d334c762277962dfcbf957973c6","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202505093400502156.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1880383366.USD","LU1267930227.SGD","BK4527","BK4531","BK1589","LU0251143458.SGD","LU1048596156.SGD","BK1515","LU0880133367.SGD","LU1152091168.USD","LU0067412154.USD","IE00BFMHRM44.USD","LU0128525689.USD","LU1242518857.USD","LU1515016050.SGD","BK1610","LU1282648689.USD","BABA","BK1571","LU1105468828.SGD","BK4554","BK4505","BK4585","IE00B0JY6N72.USD","LU1008478684.HKD","LU1688375341.USD","LU1051768304.USD","BK4503","BK4504","LU0651946864.USD","LU1051769294.HKD","BK4607","LU0047713382.USD","LU1048588211.SGD","09988","BK4588","LU0310800965.SGD","LU0979878070.USD","BK4220","LU0918141887.USD","BK4526","LU1823568750.SGD","BK4122","BK4565","LU0348816934.USD","BK4524","BK1142","LU0052756011.USD","LU0821914370.USD","00241"],"gpt_icon":1},{"id":"2534011288","title":"阿里健康(00241)出现大手买入180万股，成交价$5.01，涉资901.8万","url":"https://stock-news.laohu8.com/highlight/detail?id=2534011288","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534011288?lang=zh_cn&edition=fundamental","pubTime":"2025-05-09 10:40","pubTimestamp":1746758400,"startTime":"0","endTime":"0","summary":"[大手成交]阿里健康(00241)在上午10:40出现大手买入，成交量为180万，成交价为港币$5.01，涉资901.8万。至目前为止，股价跌1.768%，今日最高价为$5.13，而最低价为$5.0，总成交量为1.827千万股，总成交金额港币$9.225千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150431576_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150431576_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2505095381/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1502","BK1610","BK1515","BK1189","BK1501","BK1142","BK1584","BK1617","BK1615","BK1247","BK1591","BK1571","BK1589","00241"],"gpt_icon":0},{"id":"2534771114","title":"歌礼制药-B：早盘涨 5.55% 肥胖症药物新进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2534771114","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534771114?lang=zh_cn&edition=fundamental","pubTime":"2025-05-09 10:36","pubTimestamp":1746758205,"startTime":"0","endTime":"0","summary":"【歌礼制药-B 早盘上涨 5.55% 现报 7.04 港元 成交额 946.35 万港元】歌礼制药近日称将在西班牙马拉加举行的第 32 届欧洲肥胖症大会上，以口头和壁报形式报告肥胖症候选药物 ASC47 的早期研究。ASC47 是歌礼自主研发的、脂肪靶向、超长效皮下注射选择性小分子激动剂。美国食品药品监督管理局已批准 ASC47 与司美格鲁肽联用治疗肥胖症的新药临床试验申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050910471694f13969&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050910471694f13969&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","01672","BK1191","01477","BK1515","BK1161"],"gpt_icon":0},{"id":"2534063142","title":"【银河医药程培】公司点评丨百济神州 ：海外放量超预期，创新管线迎来拐点","url":"https://stock-news.laohu8.com/highlight/detail?id=2534063142","media":"中国银河证券研究","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534063142?lang=zh_cn&edition=fundamental","pubTime":"2025-05-09 09:54","pubTimestamp":1746755699,"startTime":"0","endTime":"0","summary":"核心产品海外放量超预期，25年指引经营性现金流转正。2024年全年公司营业收入同比增长56.19%，归母净亏损同比收窄25.87%，主要系核心产品泽布替尼海外持续商业化放量。多项自主研发管线迎来价值拐点。投资建议百济神州作为聚焦创新药研发生产和全球商业化的龙头企业，其核心产品具备同类最佳特质，血液瘤领导地位进一步巩固，多项自主研发管线即将迎来价值拐点。公司评级推荐：相对基准指数涨幅20%以上。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509135012a477b25c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509135012a477b25c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1588","LU2328871848.SGD","09939","688235","LU1969619763.USD","ONC","LU0307460666.USD","BK1574","LU0588546209.SGD","06160","BK1500","BK1583","BK1161"],"gpt_icon":0},{"id":"2534311323","title":"歌礼制药-B早盘涨超5% 将公布肥胖症候选药物ASC47早期研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2534311323","media":"新浪港股","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534311323?lang=zh_cn&edition=fundamental","pubTime":"2025-05-09 09:39","pubTimestamp":1746754740,"startTime":"0","endTime":"0","summary":"　　歌礼制药-B早盘上涨5.55%，现报7.04港元，成交额946.35万港元。　　歌礼制药近日宣布将在西班牙马拉加举行的第32届欧洲肥胖症大会上以口头和壁报形式报告脂肪靶向、减重不减肌的肥胖症候选药物ASC47的早期研究。据悉，ASC47是一款由歌礼自主研发的、脂肪靶向、超长效皮下注射的甲状腺激素受体β选择性小分子激动剂。美国食品药品监督管理局已批准ASC47与司美格鲁肽联用治疗肥胖症的新药临床试验申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-05-09/doc-inevxmae4609428.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","01672","01477","BK1161","BK1191","BK1574"],"gpt_icon":0},{"id":"2534116085","title":"京东健康盘中异动 股价大跌3.02%报36.900港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534116085","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534116085?lang=zh_cn&edition=fundamental","pubTime":"2025-05-09 09:36","pubTimestamp":1746754613,"startTime":"0","endTime":"0","summary":"2025年05月09日早盘09时36分，京东健康股票出现波动，股价大幅跳水3.02%。截至发稿，该股报36.900港元/股，成交量82.3962万股，换手率0.03%，振幅2.37%。京东健康股票所在的药品分销行业中，整体跌幅为0.08%。其相关个股中，金活医药集团、思派健康、药师帮涨幅较大，振幅较大的相关个股有满贯集团、京东健康、药师帮，振幅分别为4.40%、2.37%、2.03%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509093656aa2c886e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509093656aa2c886e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1591","BK1247","BK1589","86618","06618","BK1583","BK1515","LU0051755006.USD","BK1615","LU0456827905.SGD","BK1142","BK1571"],"gpt_icon":0}],"pageSize":20,"totalPage":18,"pageCount":3,"totalSize":345,"code":"91000000","status":"200"}]}}